05/23/2025 05:00
Curatis discloses Corticorelin as active substance of C-PTBE-01

An epidemiological market study commissioned by Curatis Holding AG (SIX:CURN, “Curatis”) shows that the target patient group is substantially larger than previous estimates. In the US alone, over 150,000 patients suffer from peritumoral brain edema in association with malignant tumors. In previous clinical studies, human corticorelin (C-PTBE-01), demonstrated significant benefits in the treatment of PTBE. “The prospect of developing a potential blockbuster drug with that can contribute signific...

04/22/2025 16:00
3Degrees Appoints Philippe Vedrenne as Chief Executive Officer, Effective May 1, 2025

3Degrees, a leading global climate solutions provider and certified B Corporation, is pleased to announce the appointment of Philippe Vedrenne as Chief Executive Officer (CEO), effective May 1, 2025. Vedrenne is moving into the role as 3Degrees’ current CEO and co-founder Steve McDougal steps away from leadership of the company. McDougal informed the Board of Directors last year that he would be retiring as CEO; he will maintain his involvement as a member of the Board. This press release featu...

05/05/2025 12:39
Aster Guardians Global Nursing Award Unveils Top 10 Finalists for 2025

The Aster Guardians Global Nursing Award has today announced its Top 10 finalists for 2025, one of whom will go on to win the grand prize of USD 250,000. The finalists for the fourth edition of the awards were selected from a pool of 100,000+ registrations received from 199* countries worldwide. These finalists were selected following a rigorous evaluation process, led by esteemed expert jury and grand jury panels. The entire process was independently moderated by the appointed "Process Advisor...